Business
Tempus Exhibits 4 Abstracts at the 2025 American College of Cardiology Annual Meeting
CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care,
About this update from Tempus Ai, Inc.
[{"type":"text","content":" CHICAGO--(BUSINESS WIRE)--\nTempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the company is scheduled to exhibit 4 abstracts at the American College of Cardiology (ACC) Annual Meeting, which convenes from March 29-31 in Chicago, Illinois. This is the first year that Tempus is presenting research, all of which highlights the application of AI to support clinicians in delivering personalized care.\n\n“Tempus is committed to enabling clinicians to provide better, guideline-recommended care to patients who may have undiagnosed or undertreated cardiovascular disease,” said Brandon Fornwalt, MD, PhD, Senior Vice President of Cardiology at Tempus. “Through our vast connected network of providers and ability to deliver AI-enabled insights at scale, we can help clinicians close care gaps for patients in a way that wasn’t possible before.”\n\nHighlights from Tempus’ abstracts include:\n\n\nAbstract 184: Development of machine learning models incorporating clinical, demographic, and echocardiography variables for predicting left ventricular systolic dysfunction in patients with isolated left ventricular dilation\n\n\nSession Date & Time: Saturday, March 29, 9:30 AM CDT\n\n\nOverview: The goal of this study is to create predictive models for the development of left ventricular (LV) systolic dysfunction in patients with isolated LV dilation (ILVD). This preliminary work identifies predictors and demonstrates the ability to predict progression in patients with ILVD.\n\n\n\n\n\n\nAbstract 140: Implementation of EHR-integrated notifications on patients at risk for sudden cardiac arrest\n\n\nSession Date & Time: Saturday, March 29, 11:00 AM CDT\n\n\nOverview: This study looks at the implementation of electronic health record (EHR) integrated notifications to identify patients at risk for sudden cardiac arrest (SCA) who may benefit from Implantable Cardioverter Defibrillators (ICD). The conclusion is EHR-integrated notifications can help close care gaps for undermanaged patients at risk for SCA.\n\n\n\n\n\n\nAbstract 127: Addressing racial disparities in valvular heart disease: the role of echo-driven EHR alerts in improving care access\n\n\nSession Date & Time: Saturday, March 29, 11:00 AM CDT\n\n\nOverview: The focus of this study is on addressing rac...